| |
| |
|
| Insider
Information: |
Lengauer Christoph |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,260 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,975,047 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,260 |
|
|
| Total
Value |
$5,975,047 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Blueprint Medicines Corp |
BPMC |
Chief Scientific Officer |
2016-04-13 |
56,657 |
|
0 |
Premium* |
|
|
Hookipa Pharma Inc. |
HOOK |
Director |
2020-10-21 |
4,603 |
2020-10-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HOOK |
Hookipa Pharma Inc. |
Director |
– • – |
2020-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,603 |
4,603 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2016-04-13 |
4 |
AS |
$20.01 |
$317,599 |
D/D |
(15,872) |
56,657 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2016-04-12 |
4 |
AS |
$20.01 |
$206,423 |
D/D |
(10,316) |
72,529 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2016-04-11 |
4 |
AS |
$20.30 |
$173,301 |
D/D |
(8,537) |
82,845 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2016-03-24 |
4 |
OE |
$1.49 |
$31,030 |
D/D |
19,167 |
91,382 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2015-12-17 |
4 |
AS |
$25.14 |
$162,480 |
D/D |
(6,463) |
72,215 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2015-12-16 |
4 |
AS |
$25.03 |
$604,625 |
D/D |
(24,156) |
78,678 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2015-12-15 |
4 |
AS |
$25.00 |
$12,500 |
D/D |
(500) |
102,834 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2015-11-03 |
4 |
AS |
$20.98 |
$770,679 |
D/D |
(36,734) |
103,334 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific Officer |
• – – |
2015-11-02 |
4 |
AS |
$21.10 |
$1,018,370 |
D/D |
(48,264) |
140,068 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific OfficerOffice |
• – – |
2015-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
163,636 |
|
- |
|
| BPMC |
Blueprint Medicines Corp |
Chief Scientific OfficerOffice |
• – – |
2015-04-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
188,332 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
